Skip to main content
Figure 2 | Chinese Journal of Cancer

Figure 2

From: Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival

Figure 2

Overall survival (OS) curves for DLBCL patients. A, the trends of OS curves for patients with or without HBV reactivation during rituximab-containing chemotherapy were similar. B, the trends of OS curves for patients with or without hepatitis were similar. C, the trends of OS curves for patients with resolved hepatitis B and HBsAg-negative/HBcAb-negative patients were also similar. Abbreviations as in Figure 1.

Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us